池畔

Chipan Biotech is a synthetic biology company based in Shanghai, China, specializing in the directed evolution and high-throughput screening of enzymes and functional proteins. The company leverages a proprietary microfluidic-based platform to rapidly discover and optimize biocatalysts for applications in molecular diagnostics, nucleic acid therapeutics, and industrial biotechnology. Their product portfolio includes high-performance DNA polymerases, reverse transcriptases, and other essential reagents for NGS and PCR workflows. By integrating protein engineering with advanced screening technologies, Chipan Biotech aims to provide high-quality, customized enzyme solutions that overcome the limitations of natural proteins. The company was founded in 2021 and has received significant investment from prominent venture capital firms including Sequoia China and CasStar.